Showing results (61-70 of 313) with videos related to

Sort By:
Pageof 32
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Expectations of serious adverse events at the end of life of patients with acute myeloid leukemia who receive salvage therapyMarylou Cardenas-Turanzas, Farhad Ravandi-Kashani, Jorge E Cortes, et al.
Molecular Cancer Research : MCR|March 3, 2011
STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cellsZhiming Liu, Inbal Hazan-Halevy, David M Harris, et al.
Cancer|August 31, 2010
Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapyFarshid Dayyani, Hagop Kantarjian, Susan O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemiaJessica C Pahler, Stacey Ruiz, Irina Niemer, et al.
Cancer|February 22, 2002
Central nervous system relapse in adults with acute lymphoblastic leukemiaUsha R Surapaneni, Jorge E Cortes, Deborah Thomas, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Patterns of molecular response to and relapse after combination of sorafenib, idarubicin, and cytarabine in patients with FLT3 mutant acute myeloid leukemiaAref Al-Kali, Jorge Cortes, Stefan Faderl, et al.
Leukemia Research|January 18, 2003
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemiaEfrosyni Apostolidou, Elihu Estey, Jorge Cortes, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phaseFabio P S Santos, Hagop Kantarjian, David McConkey, et al.
Blood|October 22, 2008
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemiaSusan M O'Brien, David F Claxton, Michael Crump, et al.
Cancer|June 12, 2009
Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failureAlfonso Quintás-Cardama, Fabio Pires De Souza Santos, Hagop Kantarjian, et al.
Pageof 32